Logo image of NUS.MI

NUSCO SPA (NUS.MI) Stock Fundamental Analysis

Europe - BIT:NUS - IT0005453110 - Common Stock

0.9 EUR
+0.01 (+0.56%)
Last: 10/1/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NUS. NUS was compared to 23 industry peers in the Building Products industry. Both the profitability and the financial health of NUS get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, NUS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

NUS had positive earnings in the past year.
In the past year NUS had a positive cash flow from operations.
Of the past 5 years NUS 4 years were profitable.
In multiple years NUS reported negative operating cash flow during the last 5 years.
NUS.MI Yearly Net Income VS EBIT VS OCF VS FCFNUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.65%, NUS is in the better half of the industry, outperforming 60.87% of the companies in the same industry.
The Return On Equity of NUS (10.07%) is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 9.38%, NUS is doing good in the industry, outperforming 73.91% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NUS is significantly below the industry average of 10.74%.
The 3 year average ROIC (5.20%) for NUS is below the current ROIC(9.38%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.65%
ROE 10.07%
ROIC 9.38%
ROA(3y)2.06%
ROA(5y)1.21%
ROE(3y)4.83%
ROE(5y)2.67%
ROIC(3y)5.2%
ROIC(5y)4.53%
NUS.MI Yearly ROA, ROE, ROICNUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

The Profit Margin of NUS (4.70%) is comparable to the rest of the industry.
NUS has a better Operating Margin (9.15%) than 69.57% of its industry peers.
In the last couple of years the Operating Margin of NUS has grown nicely.
NUS has a Gross Margin of 31.13%. This is in the lower half of the industry: NUS underperforms 60.87% of its industry peers.
NUS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.15%
PM (TTM) 4.7%
GM 31.13%
OM growth 3Y75.38%
OM growth 5Y49.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.34%
GM growth 5Y-0.9%
NUS.MI Yearly Profit, Operating, Gross MarginsNUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

NUS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
NUS has less shares outstanding than it did 1 year ago.
NUS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NUS is higher compared to a year ago.
NUS.MI Yearly Shares OutstandingNUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M
NUS.MI Yearly Total Debt VS Total AssetsNUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

NUS has an Altman-Z score of 2.01. This is not the best score and indicates that NUS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of NUS (2.01) is worse than 60.87% of its industry peers.
The Debt to FCF ratio of NUS is 43.85, which is on the high side as it means it would take NUS, 43.85 years of fcf income to pay off all of its debts.
NUS has a Debt to FCF ratio of 43.85. This is in the lower half of the industry: NUS underperforms 73.91% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that NUS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.23, NUS is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 43.85
Altman-Z 2.01
ROIC/WACC1.39
WACC6.74%
NUS.MI Yearly LT Debt VS Equity VS FCFNUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

2.3 Liquidity

NUS has a Current Ratio of 1.76. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NUS (1.76) is better than 78.26% of its industry peers.
A Quick Ratio of 1.31 indicates that NUS should not have too much problems paying its short term obligations.
NUS has a Quick ratio of 1.31. This is in the better half of the industry: NUS outperforms 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.31
NUS.MI Yearly Current Assets VS Current LiabilitesNUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 110.49% over the past year.
NUS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.37%.
Measured over the past years, NUS shows a very strong growth in Revenue. The Revenue has been growing by 25.88% on average per year.
EPS 1Y (TTM)110.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.98%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y54.41%
Revenue growth 5Y25.88%
Sales Q2Q%7.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUS.MI Yearly Revenue VS EstimatesNUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.43, the valuation of NUS can be described as very cheap.
NUS's Price/Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 95.65% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.90, NUS is valued rather cheaply.
Industry RankSector Rank
PE 6.43
Fwd PE N/A
NUS.MI Price Earnings VS Forward Price EarningsNUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

NUS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NUS is cheaper than 95.65% of the companies in the same industry.
NUS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. NUS is more expensive than 69.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 71.14
EV/EBITDA 3.74
NUS.MI Per share dataNUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUSCO SPA

BIT:NUS (10/1/2025, 7:00:00 PM)

0.9

+0.01 (+0.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.71%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.95M
Analysts80
Price Target2.24 (148.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.43
Fwd PE N/A
P/S 0.31
P/FCF 71.14
P/OCF 22.14
P/B 0.66
P/tB 0.83
EV/EBITDA 3.74
EPS(TTM)0.14
EY15.56%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY1.41%
OCF(TTM)0.04
OCFY4.52%
SpS2.94
BVpS1.37
TBVpS1.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 10.07%
ROCE 15.43%
ROIC 9.38%
ROICexc 10.02%
ROICexgc 12.22%
OM 9.15%
PM (TTM) 4.7%
GM 31.13%
FCFM 0.43%
ROA(3y)2.06%
ROA(5y)1.21%
ROE(3y)4.83%
ROE(5y)2.67%
ROIC(3y)5.2%
ROIC(5y)4.53%
ROICexc(3y)5.63%
ROICexc(5y)4.83%
ROICexgc(3y)7.05%
ROICexgc(5y)5.8%
ROCE(3y)8.55%
ROCE(5y)7.45%
ROICexcg growth 3Y120.86%
ROICexcg growth 5Y49.83%
ROICexc growth 3Y118.36%
ROICexc growth 5Y48.69%
OM growth 3Y75.38%
OM growth 5Y49.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.34%
GM growth 5Y-0.9%
F-Score8
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 43.85
Debt/EBITDA 0.86
Cap/Depr 30.84%
Cap/Sales 0.95%
Interest Coverage 250
Cash Conversion 11.31%
Profit Quality 9.16%
Current Ratio 1.76
Quick Ratio 1.31
Altman-Z 2.01
F-Score8
WACC6.74%
ROIC/WACC1.39
Cap/Depr(3y)720.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)25.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.37%
Revenue growth 3Y54.41%
Revenue growth 5Y25.88%
Sales Q2Q%7.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y77.89%
EBIT growth 3Y170.8%
EBIT growth 5Y87.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.18%
FCF growth 3YN/A
FCF growth 5Y-37.19%
OCF growth 1Y140.15%
OCF growth 3Y-6.63%
OCF growth 5Y-29.6%